Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Polyfunctionality of CD4+ T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma.

Doescher J, Jeske S, Weissinger SE, Brunner C, Laban S, Bölke E, Hoffmann TK, Whiteside TL, Schuler PJ.

Strahlenther Onkol. 2018 May;194(5):392-402. doi: 10.1007/s00066-018-1289-z. Epub 2018 Apr 16.

PMID:
29663037
2.

The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma.

Ziebart A, Huber U, Jeske S, Laban S, Doescher J, Hoffmann TK, Brunner C, Jackson EK, Schuler PJ.

Oncotarget. 2017 Dec 20;9(5):5834-5847. doi: 10.18632/oncotarget.23533. eCollection 2018 Jan 19.

3.

Human Papillomavirus Immunity in Oropharyngeal Cancer: Time to Change the Game?

Laban S, Hoffmann TK.

Clin Cancer Res. 2018 Feb 1;24(3):505-507. doi: 10.1158/1078-0432.CCR-17-2991. Epub 2017 Nov 13.

PMID:
29133574
4.

Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.

Krupar R, Hautmann MG, Pathak RR, Varier I, McLaren C, Gaag D, Hellerbrand C, Evert M, Laban S, Idel C, Sandulache V, Perner S, Bosserhoff AK, Sikora AG.

Am J Pathol. 2018 Jan;188(1):72-83. doi: 10.1016/j.ajpath.2017.09.013. Epub 2017 Oct 27.

PMID:
29107073
5.

Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.

Nikolic T, Woittiez NJC, van der Slik A, Laban S, Joosten A, Gysemans C, Mathieu C, Zwaginga JJ, Koeleman B, Roep BO.

Genes Immun. 2017 Sep;18(3):176-183. doi: 10.1038/gene.2017.18. Epub 2017 Aug 10.

PMID:
28794505
6.

Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer.

Theodoraki MN, Lorenz K, Lotfi R, Fürst D, Tsamadou C, Jaekle S, Mytilineos J, Brunner C, Theodorakis J, Hoffmann TK, Laban S, Schuler PJ.

Photodiagnosis Photodyn Ther. 2017 Sep;19:194-201. doi: 10.1016/j.pdpdt.2017.05.015. Epub 2017 May 31.

PMID:
28578124
7.

Novel Treatment Options in Head and Neck Cancer.

Schuler PJ, Laban S, Doescher J, Bullinger L, Hoffmann TK.

Oncol Res Treat. 2017;40(6):342-346. doi: 10.1159/000477254. Epub 2017 May 17. Review.

8.

Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes.

Kracht MJ, van Lummel M, Nikolic T, Joosten AM, Laban S, van der Slik AR, van Veelen PA, Carlotti F, de Koning EJ, Hoeben RC, Zaldumbide A, Roep BO.

Nat Med. 2017 Apr;23(4):501-507. doi: 10.1038/nm.4289. Epub 2017 Feb 27.

PMID:
28263308
9.

Response Evaluation in Head and Neck Oncology: Definition and Prediction.

Hoffmann TK, Schuler PJ, Laban S, Grässlin R, Beer M, Beer AJ, Friebe-Hoffmann U, Bullinger L, Möller P, Wiegel T.

ORL J Otorhinolaryngol Relat Spec. 2017;79(1-2):14-23. doi: 10.1159/000455726. Epub 2017 Feb 24. Review.

PMID:
28231577
10.

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.

Laban S, Giebel G, Klümper N, Schröck A, Doescher J, Spagnoli G, Thierauf J, Theodoraki MN, Remark R, Gnjatic S, Krupar R, Sikora AG, Litjens G, Grabe N, Kristiansen G, Bootz F, Schuler PJ, Brunner C, Brägelmann J, Hoffmann TK, Perner S.

Oncotarget. 2017 Feb 28;8(9):14719-14735. doi: 10.18632/oncotarget.14830.

11.

Insecticidal effects of deltamethrin in laboratory and field populations of Culicoides species: how effective are host-contact reduction methods in India?

De Keyser R, Cassidy C, Laban S, Gopal P, Pickett JA, Reddy YK, Prasad M, Prasad G, Chirukandoth S, Senthilven K, Carpenter S, Logan JG.

Parasit Vectors. 2017 Jan 31;10(1):54. doi: 10.1186/s13071-017-1992-0.

12.

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism.

Braig F, Kriegs M, Voigtlaender M, Habel B, Grob T, Biskup K, Blanchard V, Sack M, Thalhammer A, Ben Batalla I, Braren I, Laban S, Danielczyk A, Goletz S, Jakubowicz E, Märkl B, Trepel M, Knecht R, Riecken K, Fehse B, Loges S, Bokemeyer C, Binder M.

Cancer Res. 2017 Mar 1;77(5):1188-1199. doi: 10.1158/0008-5472.CAN-16-0754. Epub 2016 Dec 28.

13.

[Immunotherapy for HNSCC : Quo vadis?].

Döscher J, Busch CJ, Schuler PJ, Laban S.

HNO. 2016 Oct;64(10):700-7. doi: 10.1007/s00106-016-0241-8. Review. German.

PMID:
27624904
14.

[Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].

Busch CJ, Laban S, Knecht R, Hoffmann TK.

HNO. 2016 Oct;64(10):708-16. doi: 10.1007/s00106-016-0238-3. Review. German.

PMID:
27604282
15.

DNA barcoding and surveillance sampling strategies for Culicoides biting midges (Diptera: Ceratopogonidae) in southern India.

Harrup LE, Laban S, Purse BV, Reddy YK, Reddy YN, Byregowda SM, Kumar N, Purushotham KM, Kowalli S, Prasad M, Prasad G, Bettis AA, De Keyser R, Logan J, Garros C, Gopurenko D, Bellis G, Labuschagne K, Mathieu B, Carpenter S.

Parasit Vectors. 2016 Aug 22;9:461. doi: 10.1186/s13071-016-1722-z.

16.

Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.

de Jong VM, van der Slik AR, Laban S, van 't Slot R, Koeleman BP, Zaldumbide A, Roep BO.

Genes Immun. 2016 Sep;17(6):342-8. doi: 10.1038/gene.2016.29. Epub 2016 Jul 28.

PMID:
27467285
17.

Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.

Theodoraki MN, Lorenz KJ, Schneider J, Thierauf JC, Spagnoli G, Schuler PJ, Hoffmann TK, Laban S.

Anticancer Res. 2016 Aug;36(8):3973-82.

PMID:
27466502
18.

Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.

Kurzweg T, Kimmeyer J, Knecht R, Hoffmann TK, Busch CJ, Lörincz BB, Schuler PJ, Laban S.

HNO. 2016 Jul;64(7):501-7. doi: 10.1007/s00106-016-0191-1.

PMID:
27357174
19.

Palliative treatment standards for head and neck squamous cell carcinoma : Survey of clinical routine in German-speaking countries.

Laban S, Kimmeyer J, Knecht R, Hoffmann TK, Busch CJ, Veit JA, Möckelmann N, Kurzweg T.

HNO. 2016 Jul;64(7):487-93. doi: 10.1007/s00106-016-0187-x.

PMID:
27299894
20.

Oncologic treatment landscape for head and neck squamous cell carcinoma : Treatment infrastructure in German-speaking countries.

Kimmeyer J, Kurzweg T, Hoffmann TK, Knecht R, Veit JA, Möckelmann N, Münscher A, Laban S.

HNO. 2016 Jul;64(7):494-500. doi: 10.1007/s00106-016-0188-9.

PMID:
27286727
21.

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.

Braig F, Voigtlaender M, Schieferdecker A, Busch CJ, Laban S, Grob T, Kriegs M, Knecht R, Bokemeyer C, Binder M.

Oncotarget. 2016 Jul 12;7(28):42988-42995. doi: 10.18632/oncotarget.8943.

22.

Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.

Varier I, Keeley BR, Krupar R, Patsias A, Dong J, Gupta N, Parasher AK, Genden EM, Miles BA, Teng M, Bakst RL, Gupta V, Misiukiewicz KJ, Chiao EY, Scheurer ME, Laban S, Zhang D, Ye F, Cui M, Demicco EG, Posner MR, Sikora AG.

Head Neck. 2016 Sep;38(9):1330-7. doi: 10.1002/hed.24442. Epub 2016 Apr 15.

PMID:
27080140
23.

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.

Möckelmann N, Rieckmann T, Busch CJ, Becker B, Gleißner L, Hoffer K, Omniczynski M, Steinmeister L, Laban S, Grénman R, Petersen C, Rothkamm K, Dikomey E, Knecht R, Kriegs M.

Oncotarget. 2016 Apr 26;7(17):23542-51. doi: 10.18632/oncotarget.8275.

24.

Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.

van Lummel M, van Veelen PA, de Ru AH, Janssen GM, Pool J, Laban S, Joosten AM, Nikolic T, Drijfhout JW, Mearin ML, Aanstoot HJ, Peakman M, Roep BO.

J Immunol. 2016 Apr 15;196(8):3253-63. doi: 10.4049/jimmunol.1501282. Epub 2016 Mar 4.

25.

[Immunomodulation as innovative therapy for head and neck tumors : Current developments].

Schuler PJ, Doescher JC, Laban S, Hoffmann TK.

HNO. 2016 Jul;64(7):470-8. doi: 10.1007/s00106-016-0131-0. Review. German.

PMID:
26912050
26.

Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.

Veit JA, Heine D, Thierauf J, Lennerz J, Shetty S, Schuler PJ, Whiteside T, Beutner D, Meyer M, Grünewald I, Ritter G, Gnjatic S, Sikora AG, Hoffmann TK, Laban S.

Head Neck. 2016 Jul;38(7):1008-16. doi: 10.1002/hed.24403. Epub 2016 Feb 13.

27.

Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.

Zielinski V, Laban S, Tribius S, Schafhausen P, Veldhoen S, Knecht R, Clauditz T, Muenscher A.

Ear Nose Throat J. 2016 Jan;95(1):23-8. Review.

PMID:
26829682
28.

Re-Emergence of a Novel H5N1 Avian Influenza Virus Variant Subclade 2.2.1.1 in Egypt During 2014.

Rohaim MA, El-Naggar RF, Hamoud MM, Nasr SA, Ismael E, Laban SE, Ahmed HA, Munir M.

Transbound Emerg Dis. 2017 Aug;64(4):1306-1312. doi: 10.1111/tbed.12472. Epub 2016 Jan 22.

PMID:
26801667
29.

Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.

van Lummel M, van Veelen PA, de Ru AH, Pool J, Nikolic T, Laban S, Joosten A, Drijfhout JW, Gómez-Touriño I, Arif S, Aanstoot HJ, Peakman M, Roep BO.

Diabetes. 2016 Mar;65(3):732-41. doi: 10.2337/db15-1031. Epub 2015 Dec 30.

30.

Variation in the CTLA4 3'UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes.

de Jong VM, Zaldumbide A, van der Slik AR, Laban S, Koeleman BP, Roep BO.

Genes Immun. 2016 Jan-Feb;17(1):75-8. doi: 10.1038/gene.2015.51. Epub 2015 Dec 10.

PMID:
26656450
31.

T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.

Beringer DX, Kleijwegt FS, Wiede F, van der Slik AR, Loh KL, Petersen J, Dudek NL, Duinkerken G, Laban S, Joosten A, Vivian JP, Chen Z, Uldrich AP, Godfrey DI, McCluskey J, Price DA, Radford KJ, Purcell AW, Nikolic T, Reid HH, Tiganis T, Roep BO, Rossjohn J.

Nat Immunol. 2015 Nov;16(11):1153-61. doi: 10.1038/ni.3271. Epub 2015 Oct 5.

PMID:
26437244
32.

Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.

Thierauf J, Veit JA, Affolter A, Bergmann C, Grünow J, Laban S, Lennerz JK, Grünmüller L, Mauch C, Plinkert PK, Hess J, Hoffmann TK.

Melanoma Res. 2015 Dec;25(6):503-9. doi: 10.1097/CMR.0000000000000197.

PMID:
26352784
33.

[Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015].

Laban S, Doescher J, Schuler PJ, Bullinger L, Brunner C, Veit JA, Hoffmann TK.

HNO. 2015 Sep;63(9):612-9. doi: 10.1007/s00106-015-0054-1. German.

PMID:
26319429
34.

Evaluation of Customized Prosthesis for Irregularly Formed Tracheostoma After Laryngectomy.

Doescher J, Scheckenbach K, Angerstein W, Veit JA, Laban S, Thierauf J, Theodoraki MN, Greve J, Schuler PJ, Hoffmann TK.

Ann Otol Rhinol Laryngol. 2016 Feb;125(2):145-50. doi: 10.1177/0003489415601686. Epub 2015 Aug 25.

PMID:
26307069
35.

Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.

Kriegs M, Gurtner K, Can Y, Brammer I, Rieckmann T, Oertel R, Wysocki M, Dorniok F, Gal A, Grob TJ, Laban S, Kasten-Pisula U, Petersen C, Baumann M, Krause M, Dikomey E.

Radiother Oncol. 2015 Apr;115(1):120-7. doi: 10.1016/j.radonc.2015.02.018. Epub 2015 Mar 18.

PMID:
25796091
36.

Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.

Elbaz M, Yanay N, Laban S, Rabie M, Mitrani-Rosenbaum S, Nevo Y.

Cell Death Dis. 2015 Mar 12;6:e1690. doi: 10.1038/cddis.2015.60.

37.

MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinoma.

Veit JA, Scheckenbach K, Schuler PJ, Laban S, Wiggenhauser PS, Thierauf J, Klussmann JP, Hoffmann TK.

Anticancer Res. 2015 Mar;35(3):1271-7. Erratum in: Anticancer Res. 2015 Dec;35(12):6993. Wiggenhauser, Severin P [corrected to Wiggenhauser, Paul Severin].

PMID:
25750274
38.

[Molecular approaches to systemic therapy of adenoid cystic carcinoma of the head and neck area].

Büchsenschütz K, Veit JA, Schuler PJ, Thierauf J, Laban S, Fahimi F, Bankfalvi A, Lang S, Sauerwein W, Hoffmann TK.

Laryngorhinootologie. 2014 Oct;93(10):657-64. doi: 10.1055/s-0034-1382024. Epub 2014 Oct 10. Review. German.

PMID:
25302595
39.

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.

Laban S, Atanackovic D, Luetkens T, Knecht R, Busch CJ, Freytag M, Spagnoli G, Ritter G, Hoffmann TK, Knuth A, Sauter G, Wilczak W, Blessmann M, Borgmann K, Muenscher A, Clauditz TS.

Int J Cancer. 2014 Sep 1;135(5):1142-52. doi: 10.1002/ijc.28752. Epub 2014 Feb 11.

40.

Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation.

Laban S, Steinmeister L, Gleißner L, Grob TJ, Grénman R, Petersen C, Gal A, Knecht R, Dikomey E, Kriegs M.

Radiother Oncol. 2013 Nov;109(2):286-92. doi: 10.1016/j.radonc.2013.07.003. Epub 2013 Aug 13.

PMID:
23953412
41.

New treatment strategies for HPV-positive head and neck cancer.

Kofler B, Laban S, Busch CJ, Lörincz B, Knecht R.

Eur Arch Otorhinolaryngol. 2014 Jul;271(7):1861-7. doi: 10.1007/s00405-013-2603-0. Epub 2013 Aug 10. Review.

PMID:
23934317
42.

HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.

Busch CJ, Kriegs M, Laban S, Tribius S, Knecht R, Petersen C, Dikomey E, Rieckmann T.

Radiother Oncol. 2013 Sep;108(3):495-9. doi: 10.1016/j.radonc.2013.06.035. Epub 2013 Aug 7.

PMID:
23932155
43.

[The development of TORS in Europe].

Lörincz BB, Laban S, Knecht R.

HNO. 2013 Apr;61(4):294-9. doi: 10.1007/s00106-013-2678-3. Review. German.

PMID:
23538854
44.

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up.

Möckelmann N, Laban S, Pantel K, Knecht R.

Eur Arch Otorhinolaryngol. 2014 Jan;271(1):15-21. doi: 10.1007/s00405-013-2391-6. Epub 2013 Feb 14.

PMID:
23408023
45.

Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.

Unger WW, Pearson T, Abreu JR, Laban S, van der Slik AR, der Kracht SM, Kester MG, Serreze DV, Shultz LD, Griffioen M, Drijfhout JW, Greiner DL, Roep BO.

PLoS One. 2012;7(11):e49213. doi: 10.1371/journal.pone.0049213. Epub 2012 Nov 14.

46.

[The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].

Laban S, Zielinski V, Busch CJ, Münscher A, Schafhausen P, Tribius S, Knecht R.

HNO. 2012 Nov;60(11):962-7. doi: 10.1007/s00106-012-2595-x. German.

PMID:
23114542
47.

[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].

Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T.

HNO. 2012 Nov;60(11):957-61. doi: 10.1007/s00106-012-2596-9. German.

PMID:
23114541
48.

[New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting].

Loewenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, Busch CJ.

HNO. 2012 Nov;60(11):951-6. doi: 10.1007/s00106-012-2597-8. German.

PMID:
23114540
49.

[Oncological nonsurgical treatment concepts for head and neck tumors: highlights from the 2012 ASCO annual meeting].

Laban S, Knecht R.

HNO. 2012 Nov;60(11):950. doi: 10.1007/s00106-012-2594-y. German. No abstract available.

PMID:
23114539
50.

Tolerogenic dendritic cells impede priming of naïve CD8⁺ T cells and deplete memory CD8⁺ T cells.

Kleijwegt FS, Jansen DT, Teeler J, Joosten AM, Laban S, Nikolic T, Roep BO.

Eur J Immunol. 2013 Jan;43(1):85-92. doi: 10.1002/eji.201242879. Epub 2012 Nov 12.

Supplemental Content

Support Center